Real-world data + AI = broadening access and fairness in trials
A landmark pragmatic clinical trial has demonstrated that artificial intelligence can democratize access to high quality chronic care. The study compared a fully automated AI led lifestyle intervention against a traditional human coached program for patients with prediabetes. The results showed that the AI program was non inferior delivering comparable weight loss and HbA1c reductions. By proving that an automated and scalable tool can match the effectiveness of human experts in a real world setting this study paves the way for broadening access to diabetes prevention programs. Millions of patients who currently cannot access or afford human coaching could benefit from this technology.
The findings suggest that digital interventions can effectively bridge the gap between limited clinical resources and the growing demand for chronic disease management without compromising on clinical outcomes.
Read the original article at: https://pubmed.ncbi.nlm.nih.gov/41144242/
Follow us on Instagram, Twitter, and Facebook to stay up to date with what's new in healthcare all around the world.
Comments
Post a Comment